Victory Capital Management
XENT

Victory Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Victory Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,406
Closed -$124K – 3570
2020
Q1 		$124K Buy
10,406
+3,628
+54% +$80.4K ﹤0.01% 2478
2019
Q4 		$169K Buy
6,778
+1,827
+37% +$37K ﹤0.01% 2359
2019
Q3 		$84K Buy
+4,951
New +$90.1K ﹤0.01% 2494

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management's XENT Position: Q2 2020 in Review

Victory Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 10,406 shares — an estimated $124K sold.

Victory Capital Management first reported a position in XENT in Q3 2019 and held it in 3 quarters. The position peaked at $169K in Q4 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

  • Victory Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 10,406 Intersect ENT, Inc shares in Q2 2020, an estimated $124K.
  • Victory Capital Management first reported a position in Intersect ENT, Inc in Q3 2019 and held it in 3 quarters.
  • Victory Capital Management's Intersect ENT, Inc position peaked at $169K in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.